Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Been through this before. The sky is not falling. Long's hold tight.
If it hits .10 I'm cool. I bought in @ 0.05 so I'll still have some breathing room. Thanks for looking out tho dude.
Maybe you should hit the sell button first thing in the AM. Get ahead of it. Show us how it's done.
I know. Just wondering what's bothering him or her. Seems like he or she doesn't want to make $. Just wants to be bitter. Not sure why they post here? If i was negative on a stock I'd just move on. Nonetheless I feel sorry for people and want to help. It's an Irish Catholic thing. Let's just enjoy the weather the holidays and the monster return that's coming.
Why you so mad bro?
Honestly if they do I'll be pissed. Unless it's major big time news. We have a holiday on Monday up here, and you guys have Wednesday.
I think we already hit the bottom, so if they do have news I'll take it next Thursday open or Friday close.
And I would like to wish everyone a Happy Canada Day (IME) and a Happy 4th of July (IMEXF)
Quarter 3 starts next week. Let's get this closer.
06/28/2018
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the following company is approved for trading on the OTCQB Venture Market:
Imagin Medical Inc. (CSE: IME; OTCQB: IMEXF) Imagin Medical is developing imaging solutions that will establish a new standard of care in detecting cancers and visualizing the surgical field in minimally invasive surgery. The i/Blue Imaging System integrates advanced optics, state-of-the art, high-resolution cameras and patented, image-blending technology to produce images 100X more sensitive than currently available in less than a quarter of the time of conventional systems. Imagin's initial target market is bladder cancer, a major cancer worldwide, the sixth most prevalent in the U.S., and the most costly cancer to treat due to a greater than 50% recurrence rate.
U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for this company on www.otcmarkets.com.
1 example is them listening to our pleas of getting US promo going. They took the 1st step by getting off the pinks. They didn't have to do that.
Trading on the pinks or grey market is a must to start because it's easy. But handcuffs companies from being promoted by US brokers.
Now as the story goes forward we will have more retail investors helping increase the SP at every run.
I don't care where we are now. It's a part of the game. Remember Cannabix
0.05 to 0.75 down to .11 and all the stops in between to 3.54
We will get to $$ land. Do I wish we were there already....of course! Is management experienced in publically traded companies? Obviously no. But they have a real company with real professionals Google Pam Pampineau FDA 510k. Shes a pro. We are filled with experience at every level except someone to handle the Promo and marketing for a public company. Let's see what Kilmer Lucas can do. The only price I care about is 0 and $1+
Last summer people were selling IME at 0.03. No BS. Now we're in the same boat but .21 in a horrible market! I'm not qualified to give advice but if I were I'd be saying buy buy buy at these levels.
Ya I get it. We're in tight. IME needs to put up a 3. The lack of news and the Global markets decling $1.087 Trillion in 3 days has put us here.
IME isn't the only one suffering. Still have 2 Q's left in 2018. And 2 business days in June .still have some for that June news.
Not sure when? Still listed on the pink sheets as of now.
What is really exciting is... They changed their corporate presentation. They moved the FDA and IDE applications and meetings into Q3. BUT, they left the proof of concept milestone in Q2.
That says to me that the research went well in Rochester.
We could be looking at a monster press release.
Once word finally starts to get going in the US, shares will be gobbled up.
The end game is still about a year (or more) away imo.
OTCQB certified. Brokers can now recommend IMEXF to clients in the United States. Kilmer Lucas will ramp up US promo.
I have a hunch that everything is went well in Rochester. MY OPINION
Let's see that news release by the end of the week.
OTCQB Certification
I, John F. Vacha, CFO of Imagin Medical Inc. (“the Company”), certify that:
a. The Company is registered or required to file periodic reporting with the SEC or is exempt from SEC
registration as indicated below (mark the box below that applies with an “X”):
[ ] Company is registered under Section 12(g) of the Exchange Act
[X] Company is relying on Exchange Act Rule 12g3-2(b)
[ ] Company is a bank that reports to a Bank Regulator under Section 12(i) of the Exchange Act
[ ] Company is a bank that is non-SEC reporting but is current in its reporting to a Banking Regulator
[ ] Company is reporting under Section 15(d) of the Exchange Act.
[ ] Company is reporting under the Alternative Reporting Company Disclosure Guidelines
[ ] Other (describe)
b. The Company is current in its reporting obligations as of the most recent fiscal year end and any subsequent
quarters, and such information has been posted either on the SEC’s EDGAR system or the OTC Disclosure &
News Service, as applicable.
c. The Company Profile displayed on www.otcmarkets.com is current and complete as of 06/07/2018 and includes
the total shares outstanding, authorized, and in the public float as of that date.
d. Please provide the following information as of the latest practicable date:
i. Number of Beneficial Owners holding at least 100 shares: 1,279 as of May 11, 2018
(“Beneficial Owner” shall mean any person who, directly or indirectly has or shares voting power of such
security or investment power, which includes the power to dispose, or to direct the disposition of, such
security.)
ii. Number of shares in the Public Float: 97,454,672 as of 06/04/2018
(“Public Float” shall mean the total number of unrestricted shares not held directly or indirectly by an officer,
director, any person who is the beneficial owner of more than 10 percent of the total shares outstanding, or
any Affiliates thereof, or any Immediate Family Members of officers, directors and control persons.)
e. The company is duly organized, validly existing and in good standing under the laws of British Columbia, Canada
in which the Company is organized or does business.
f. Identify any law firm and attorney(s) that acted as the Company’s primary legal counsel in preparing its most
recent annual report. Include the firm and attorney(s) name if outside counsel, or name and title if internal counsel.
(If no attorney assisted in putting together the disclosure, the Company must identify the person or persons who
prepared the disclosure and their relationship to the company.) Please also identify any other attorney, if different
than the primary legal counsel, that assisted the company during the prior fiscal year on any matter including but
not limited to, preparation of disclosure, press releases, consulting services, corporate action or merger assistance,
etc.
None
g. The following is a complete list of third party providers, including names and addresses, engaged by the
Company, its officers, directors or controlling shareholders, during the period from the Company’s prior fiscal year
end to the date of this OTCQB Certification, to provide investor relations services, public relations services,
marketing, brand awareness, consulting, stock promotion, or any other related services to the Company.
Kilmer-Lucas - 5090 Explorer Dr Suite 203, Mississauga, ON L4W 4T9, Canada
Capital Ideas – 10250 - 101 St, Suite 1803, Edmonton, Alberta , T5J 3P4
Kareg Research - 624 Avenue O, Brooklyn, N.Y. 11230
OLSSON BUSINESS ACCELERATION – Sven Ollson – OchslinstraBe 27,Goppingen,73033,DE
Public Eye – Karsten Bousche - Marksburgstr. 45,Berlin,10318,DE
Money Sense Magazine – One Mount Pleasant Road, 11th Floor, Toronto, Ontario, Canada M4Y 2Y5
Financial Buzz - 14 Wall Street NY NY 10005
Hybrid Capital - 110 Yonge Street,Suite 501,Toronto,ON,M5C 1T4,CA
Tyler Media - 1601-289 Drake Street, Vancouver BC , Canada
V6B 5Z5 Invest pitch – 3507 - 1111 West Pender Street, Vancouver BC V6E 2P4
h. The following is a complete list of Officers, Directors and Control Persons (control persons are beneficial owners
of more than five percent (5%) of any class of the issuer’s equity securities), including name, address, and number
of shares owned. Options and warrants that can be converted into common shares within the next 60 days should
be included in the shareholdings listed below. If any of the beneficial shareholders are corporate entities, provide
the name and address of the person(s) owning or controlling such corporate entities.
Name of Control Person Address (City and State only) Number of Shares Owned
Edward James Hutchens Hyannis Port, MA 7,710,500
John Vacha Naples, FL 42,000
Steven Chan Surrey, British Columbia, Canada 28,633
Robin Atlas Brookline, MA 1,055,224
Kenneth Daignault Holden, MA 550,000
This is not the news. Another one is coming. I'm going to verify this. Hopefully by days end.
If you feel up to it. 1-617-571-6006
Ask for Jim
If this is the only news I'm with you AMG
For now I am going to believe it is a sign of things to come.
Imagin Medical’s (CSE:IME; OTC:IMEXF) i/Blue Imaging System is expected to improve physicians’ ability to detect bladder cancer with minimally invasive endoscopes and reduce recurrence by dramatically improving the urologist’s ability to visualize, identify and remove cancerous cells.
“We have completed development of our prototype, an advanced optical and light sensor technology that, in conjunction with white light and near-infrared fluorescence, is expected to deliver superior images in less than 15 minutes, instead of the full hour required by conventional systems prior to use in the operating room,” Jim Hutchens, president and CEO, says in an interview with BioTuesdays.
“We believe the time savings will increase the efficiency of the operating room and reduce healthcare costs by potentially enabling procedures to be performed in the less expensive setting of a physician’s office,” he adds.
And as the i/Blue Imaging System becomes established in the urology market, Mr. Hutc ithens says Imagin plans to complete development of the i/Vision Imaging System is technology, which combines multiple illumination sources into one system.
“The i/Vision will accommodate the most commonly used fluorescing contrast agents, such as indocyanine green (ICG), and would potentially enable Imagin to expand into additional specialties such as, general surgery, gynecology, colorectal and thoracic procedures,” he contends.
The current standard of care using endoscopes with white light has been used for decades and is ripe for innovation, Mr. Hutchens suggests. “White light is highly effective for visualizing cancerous tumors that protrude above the bladder wall, but is not as effective in visualizing their margins or tumors that lie flay on the bladder surface
http://www.biotuesdays.com/features/2018/6/12/imagin-medical-taking-bladder-cancer-imaging-to-next-level
Every prediction you've made about IME has been wrong. Please keep up the bashing. I have kids in private school.
Ok you go with what you know. Thanks for the information about the urologist's taking a pass on the tech.
They trade on the pink sheets. Pink sheets means pinks sheets. Uplisting in soon. OTCQB
The stock trades on the pink sheets. Brokers cannot recomend stocks on the pinks. IMEXF is uplisting to the OTCQB any day now.
This will enable brokers to recommend and buy the stock for clients.
Things will be different very soon.
US promo is in the works.
This is a weird day for sure.
End of Tuesday it looked like accumulation was starting and that carried into Wednesday. Today it started the same, and then there appeared to be some big selloffs.
I think they are using social media because they are getting bombarded with calls. I think they are trying to divert calls that way.
Not sticking up for them, I just have a feeling alot of people bought in from .34-.44 and now they are wondering what the hell is going on with their investment.
Even if you are correct. This is a speculation game. I'm saying new highs this month. I have seen many of failures pop. This is no failure. If it takes us longer to completion, so be it. We will hit highs and new highs along the way.
I could give you several examples of companies hitting ridiculous share prices with nothing to back it up. But all you have to do is search a little and you will see it.
I strongly recommend nobody sells at these levels. It will go higher.
All my opinion. I have been long since 2016
I am long until $$ and then I will reevaluate.
The US market doesn't even know about IMEXF yet. Wait until they want shares. Uplisting soon with US promo to follow.
I'm thinking we hit new highs this month. With simple progress.
If Dr Messing signs off on this, it explodes. It will be halted several times.
CSE updated the volume total for yesterday. It seems someone did come in and scoop up about roughly 800,000 shares at the end. Or does anyone know when warrants are cashed, does it reflect on the volume?
The CSE has 2 #'s now. 1.03 mil and 314,200
Looks like someone scooped a million shares somewhere around the close. Could be news on the way.
That's USA side. I should have clarified a Canadian broker. These 2 are way apart. I'm hoping CSE is wrong.
Can anyone give me a volume total for today?
TD is saying 1.03 million and the CSE is saying 314,200.
It's on their website https://imaginmedical.com
Under corporate presentation, scroll down to competition.
In that last promo piece from the German source, they made reference to Karl Storz and Olympus being potential buyers.
Also of interesting note in that artical is this disclaimer.
The client of this publication, at the time of publication, holds shares in the company Imagin Medical Inc. and has no plans to buy or sell it in the short term. This creates the possibility of a conflict of interest
https://www.shareribs.com/technology/it-und-kommunikation/news/article/imagin_medical_vervielfachungspotenzial_dank_wunderwaffe_gegen_blasenkrebs_id108384.html
It makes me wonder who paid for this promo in Germany. It seems it didn't come from the company.
It will pop up from here with some news.
Major news it will explode.
It takes real patience with these venture start ups.
The price is stuck for now. It seems the day traders are gone for now too.
Hold what you have IME will hit the $1 + club.
I'm hearing they are uplisting on the OTC from the pink sheets to the OTCQB. This will start the U.S promo and will create a demand for our shares. Add in some news of progress and we will be ok. I've been a sharehder since 2016 I can say we are seeing the light now.
I caught that too. I'm thinking it's lost in translation.
Some interesting excerpts from the article.
The management of Imagin Medical estimates that only 7-10 sales people will be needed to market the high-margin product. But we expect Imagin Medical to be acquired after FDA approval. It's no secret that many medical technology companies are growing through acquisitions. Imagin Medical would be a perfect takeover candidate.
We regard the opportunity / risk ratio as excellent and see the share price of Imagin Medical Inc. (WKN: A2AE35 ) as 12 months ahead as target price of 1.30 CAD or 0.86 EUR. In the medium term, we can imagine a good ten times the current level if Imagin Medical is not previously acquired by a major competitor, such as Karl Storz or Olympus ( www.olympus-global.com
I have never heard Karl Storz or Olympus mentioned as potential buyers. I find it puzzling they would be mentioned by name.
Here is some promo in Germany. You may have to hit translate when you open the link.
https://www.shareribs.com/technology/it-und-kommunikation/news/article/imagin_medical_vervielfachungspotenzial_dank_wunderwaffe_gegen_blasenkrebs_id108384.html
My best guess is...
Commercialization yes
But also uplisting on the OTC... U.S promo will begin.
This will allow brokers to recommend IME South of the border and we will get a whole new crop of shareholders.
And hopefully we get a sprinkle of research study is going good.
News on the way.
Company calling for big news on Twitter feed
@_imaginmedical
Let's get this!!!!
VANCOUVER, British Columbia, May 28, 2018 (GLOBE NEWSWIRE) -- Torino Power Solutions Inc. (CSE:TPS) (Frankfurt:A143TE) (the “Company” or “Torino”), is pleased to report that it will deliver its technology to one of the largest utility companies in the northern eastern United States. The utility based in New England controls several regulated subsidiaries offering retail electricity and natural gas service to more than 3 million customers. The Torino Power Line Monitoring (PLM) sensor system will be installed at a specified location on an overhead powerline in the northern eastern US. The PLM will be installed on a pilot basis with terms for purchase after an evaluation period is completed successfully. The Company will provide further installation details and timing in the coming weeks.
Torino's patented microwave cavity sensor technology delivers real-time temperature measurements of overhead powerlines that allow for increased transmission capacity, improved grid resiliency, lower energy costs and bottleneck elimination. Torino sensors can be deployed quickly and begin transmitting real-time data to the utility almost immediately. Torino is focused on servicing utilities that are seeking new innovative sensor technology to improve grid performance and reduce cost for their customers.
Rav Mlait, CEO of Torino commented, “The Torino PLM system is unique because of our completely passive sensors (no electronics or batteries) that provide utilities with the most durable, easy to install and low-maintenance sensor system for dynamic line rating purposes in the market. Torino’s real time Power Line Monitoring systems are a marked leap forward for utilities in terms of data acquisition for IIOT ('Industrial Internet of Things') practices. We believe that our technology’s unique characteristics and price point will make it an attractive solution for utilities worldwide. We are truly excited to be begin this new installation of our technology with a major utility in the U.S.”
Please visit www.torinopower.com for more information.
We seek Safe Harbor.
On behalf of the Board of Directors
“Rav Mlait”
CEO and Director
Torino Power Solutions Inc.
For further information, contact at info@torinopower.com
Informal. Basically networking with the industries top guys from Dr's to CEO's to sales reps . Dr Messing is receiving an award at that conference, so he will there and most likely getting grilled for info on the goings on by others in the industry.
We should get a few more eyes on us.
Excellent!!!
Thanks for this.
Interesting first hour today.
Something up?
I have a feeling there is.
“This is an exciting time. With proper funding and an experienced management team in place, we’re confident 2018 will be a pivotal year,” said Jim Hutchens, Imagin’s President and CEO.